Insulin-like growth factor-1 suppresses the Myostatin signaling pathway during myogenic differentiation

A Retamales1, R Zuloaga1, C A Valenzuela1

  • 1Laboratorio de Biotecnología Molecular, Facultad de Ciencias Biológicas, Universidad Andrés Bello, Santiago, Chile.

Insights

Insulin-like Growth Factor-1 (IGF-1) inhibits Myostatin (MSTN) signaling by interacting with Smad3 via the PI3K/Akt pathway. This crosstalk promotes skeletal myoblast differentiation and myod gene expression.

Area of Science:

  • Muscle Biology
  • Cell Signaling
  • Molecular Biology

Background:

  • Myogenic differentiation is crucial for skeletal muscle formation.
  • Myostatin (MSTN) inhibits muscle growth, while Insulin-like Growth Factor-1 (IGF-1) promotes it.
  • Both MSTN and IGF-1 signaling pathways are critical regulators of skeletal myogenesis.

Purpose of the Study:

  • To investigate the functional crosstalk between IGF-1 and MSTN signaling pathways.
  • To elucidate the molecular mechanisms underlying the interaction between these two growth factor pathways.
  • To understand how IGF-1 modulates MSTN's inhibitory effects on myoblast differentiation.

Main Methods:

  • Skeletal myoblast culture and stimulation with MSTN and/or IGF-1.
  • Analysis of Smad3 activation and Smad-dependent transcription.
  • Assessment of myod gene expression and myoblast fusion.
  • Western blotting and immunoprecipitation assays to detect protein interactions.

Main Results:

  • MSTN stimulation transiently increased Smad3 activation and inhibited myod expression and myoblast fusion.
  • IGF-1 preincubation blocked MSTN-induced Smad3 activation, promoting myod expression and differentiation.
  • The inhibitory effect of IGF-1 on MSTN signaling was dependent on IGF-1 receptor, PI3K, and Akt.
  • IGF-1 pretreatment enhanced the interaction between Akt and Smad3.

Conclusions:

  • The IGF-1/PI3K/Akt pathway inhibits MSTN signaling during skeletal myoblast differentiation.
  • This study reveals a novel crosstalk mechanism between IGF-1 and MSTN pathways.
  • Understanding this interaction provides new insights into the regulation of skeletal muscle growth.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.0K
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.4K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.0K